Skip to Content

Drugs with Pharmacogenomic Tests

February 23, 2010

Drug
Atomoxetine HCI (Strattera)

Purpose
ADHD treatment

The Gene Factor
Patients with a mutation in the CYP2D6 gene are at risk of suffering serious liver damage.

Drug
Clopidogrel (Plavix)

Purpose
Prevents heart attacks by inhibiting blood clots

The Gene Factor
A variation of the CYP2C19 gene interferes with the way the drug is metabolized, rendering it ineffective.

Drug
Cetuximab (Erbitux) and Panitumumab (Vectibix)

Purpose
Colorectal cancer drug

The Gene Factor
The drugs work only in people whose tumors have a normal KRAS gene.

Drug
Gefitinib (Iressa)

Purpose
Lung cancer drug

The Gene Factor
Works best on people whose tumors have a mutation in the EGFR gene.

Drug
Irinotecan (Camptosar)

Purpose
Colorectal cancer drug

The Gene Factor
People with a genetic variant suffer side effects because they have fewer liver enzymes to break down the drug.

Drug
Tamoxifen (Nolvadex)

Purpose
Breast cancer drug

The Gene Factor
Variations in the CYP2D6 gene can make a person metabolize the drug too quickly or not at all.

Drug
Warfarin (Coumadin)

Purpose
Blood thinner

The Gene Factor
In patients with either or both of two genetic variations, the drug can cause excessive bleeding rather than help prevent blood clots. Genetic testing can reveal the right dose.

Keep Reading

Most Popular

Here’s how a Twitter engineer says it will break in the coming weeks

One insider says the company’s current staffing isn’t able to sustain the platform.

Technology that lets us “speak” to our dead relatives has arrived. Are we ready?

Digital clones of the people we love could forever change how we grieve.

How to befriend a crow

I watched a bunch of crows on TikTok and now I'm trying to connect with some local birds.

Starlink signals can be reverse-engineered to work like GPS—whether SpaceX likes it or not

Elon said no thanks to using his mega-constellation for navigation. Researchers went ahead anyway.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.